The global airway management devices market size was estimated to be US$ 1.5 billion in 2021 and is expected grow at a CAGR of 7.2% between 2023 to 2032.
Airway management devices are equipment used by clinicians to keep the airways of patients open and functional in case of emergency or physiological defects. Such devices can enable mechanical or physiological respiration and keep the intake of the lungs open. Various routes used to keep the airway functioning by use of such airway management devices are nasopharyngeal airway (NPA), oropharyngeal airway (OPA), endotracheal airway (ETA), etc.
Usually, patients can experience airway complications in case of severe infection of the lungs and throat, cardiac arrest, or after critical injuries. Such patients need immediate clearance of their airways to prevent further complications or death. As the prevalence of such diseases increase there will be growth in demand for airway management devices across the globe.
Chronic obstructive pulmonary disorders (COPD), such as bronchitis and emphysema, as well as lung cancer and other respiratory tract diseases have a substantial impact on airways and lung structures. The need for airway management devices is predicted to rise as the prevalence of chronic respiratory disorders such as asthma and COPD rises.
Furthermore, the prevalence of respiratory disorders is rising as a result of both environmental and lifestyle factors such as pollution, tobacco smoking, unhealthy lifestyles, and stress.
The market for airway management devices is being driven by an increase in the number of people who suffer from such diseases, as well as the quick introduction and availability of compact, cost-contained, and simple-to-use airway equipment for the treatment of such conditions. Airway stenting and airway clearance systems are some of the unique therapy systems available extensively in such cases also enabling the growth of the airway management devices market.
The rise in world population can be linked to a rise in the life expectancy of individuals over the past few decades. A person's immune system declines with age and this can result in an increased risk of getting different infections and heart disorders for such a population. The rapidly growing geriatric population will raise the occurrence and prevalence of persistent respiratory illnesses. This is expected to boost demand for airway management devices throughout the projected period.
The covid-19 pandemic had resulted in an increased strain on healthcare systems across the world. Because covid-19 primarily affected the lung and respiratory systems it increased the demand for airway management devices in hospital and critical care wards. All major players involved in the production of such systems ramped up their production to meet the expected demand.
This increased investment has brought down the cost of such devices and thus increased their sales further. Thus, it can be said that covid-19 pandemic positively impacted the growth of global airway management systems, and will continue to enable better growth results.
The global airway management devices are primarily segmented into the supraglottic device, infraglottic device, resuscitators, and laryngoscope. Infraglottic devices are expected to have a dominant share of this market because of technological advancements and increasing application during emergencies. In terms of end-user types, Operating rooms (OR), intensive care units (ICU), and others are major sections of the airway management devices market.
Herein, the OR segment accounted for the dominant market share compared to other types. This increase is attributed to the rise in the number of ORs in developing countries. Moreover, the use of airway management systems in ventilation machines, oxygenation, and administration of anesthesia during a surgical procedure also enables the growth of the airway management segment in the forecast period.
North America is currently the largest market for airway management systems and the trend is projected to continue positively in the coming years. Technologically advanced equipment, an increasing geriatric population, and better cost margins have enabled the growth of airway management systems in the American market.
Apart from the USA, the Europe airway management devices market is expected to show rapid progress during the forecast period. Increased initiatives by governments, increased awareness of such devices, and demand for better healthcare services are the driving factor for the growth of airway management devices.
Increased purchasing power and growth of disposable income have resulted in increased healthcare spending in the Asia Pacific region which will propel the sale of airway management systems in this region. All in all, the global airway management system has a better scope of growth within the next decade.
Airway management procedures necessitate the use of competent anaesthetists and qualified nurses. Inadequate treatment and diagnosis of significant injuries in emergencies can result in abnormalities, malfunction of the affected region, or even death. The global scarcity of anaesthetists and paramedics must be addressed as soon as possible, and it represents a potential opportunity for new market participants.
The global airway management devices market is highly consolidated with few large-scale manufacturers controlling the majority of the share. Key players involved in the airway management devices sector are GE Healthcare, Medtronic plc, Koninklijke Philips N.V, Olympus Corporation, Smiths Medical, and Karl Storz GmbH & Co. KG. Majority of these players are also adopting growth strategies like novel product design and development, agreements or partnerships, and merger & acquisitions.
By Device Type
By End-User
By Geography
Patients experiencing airway complications due to severe infection of the lungs and throat, cardiac arrest, or accidental injuries need immediate clearance of their airways to prevent complications and death. These are the primary users of airway clearance devices.
The covid-19 pandemic positively impacted the growth of global airway management systems due to increased demand for airway management devices in hospitals and critical care wards during the pandemic.
The global airway management devices market is estimated to expand at a CAGR of 7.2% through 2023 to 2032.
North America is currently the largest market for airway management systems and the trend is projected to continue positively in the coming years. Technologically advanced equipment, an increasing geriatric population, and better cost margins have enabled the growth of airway management systems in the American market.
The airway management devices market was valued at US$ 1.5 billion in 2021.
GE Healthcare, Medtronic plc, Koninklijke Philips N.V, Olympus Corporation, Smiths Medical, and Karl Storz GmbH & Co. KG. are the major players in the global airway management system market.
Copyright © 2024 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved